Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

C. Tibaldi; E. Giovannetti; E. Vasile; V. Mey; A.C. Laan; S. Nannizzi; R. Di Marsico; A. Antonuzzo; C. Orlandini; S. Ricciardi; M. Del Tacca; G.J. Peters; A. Falcone; R. Danesi

doi:https://doi.org/10.1158/1078-0432.CCR-07-1364

Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

C. Tibaldi, E. Giovannetti, E. Vasile, V. Mey, A.C. Laan, S. Nannizzi, R. Di Marsico, A. Antonuzzo, C. Orlandini, S. Ricciardi, M. Del Tacca, G.J. Peters, A. Falcone, R. Danesi

Medical oncology laboratory (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

192 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1797-1803
Journal	Clinical Cancer Research
Volume	14
Issue number	6
DOIs	https://doi.org/10.1158/1078-0432.CCR-07-1364
Publication status	Published - 2008

Access to Document

https://doi.org/10.1158/1078-0432.CCR-07-1364

Cite this

Tibaldi, C., Giovannetti, E., Vasile, E., Mey, V., Laan, A. C., Nannizzi, S., Di Marsico, R., Antonuzzo, A., Orlandini, C., Ricciardi, S., Del Tacca, M., Peters, G. J., Falcone, A., & Danesi, R. (2008). Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clinical Cancer Research, 14(6), 1797-1803. https://doi.org/10.1158/1078-0432.CCR-07-1364

@article{a312846f8dea40c1b0005529ef001c5f,

title = "Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients",

author = "C. Tibaldi and E. Giovannetti and E. Vasile and V. Mey and A.C. Laan and S. Nannizzi and {Di Marsico}, R. and A. Antonuzzo and C. Orlandini and S. Ricciardi and {Del Tacca}, M. and G.J. Peters and A. Falcone and R. Danesi",

year = "2008",

doi = "https://doi.org/10.1158/1078-0432.CCR-07-1364",

language = "Undefined/Unknown",

volume = "14",

pages = "1797--1803",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "6",

}

Tibaldi, C, Giovannetti, E, Vasile, E, Mey, V, Laan, AC, Nannizzi, S, Di Marsico, R, Antonuzzo, A, Orlandini, C, Ricciardi, S, Del Tacca, M, Peters, GJ, Falcone, A & Danesi, R 2008, 'Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients', Clinical Cancer Research, vol. 14, no. 6, pp. 1797-1803. https://doi.org/10.1158/1078-0432.CCR-07-1364

TY - JOUR

T1 - Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

AU - Tibaldi, C.

AU - Giovannetti, E.

AU - Vasile, E.

AU - Mey, V.

AU - Laan, A.C.

AU - Nannizzi, S.

AU - Di Marsico, R.

AU - Antonuzzo, A.

AU - Orlandini, C.

AU - Ricciardi, S.

AU - Del Tacca, M.

AU - Peters, G.J.

AU - Falcone, A.

AU - Danesi, R.

PY - 2008

Y1 - 2008

U2 - https://doi.org/10.1158/1078-0432.CCR-07-1364

DO - https://doi.org/10.1158/1078-0432.CCR-07-1364

M3 - Article

C2 - 18347182

SN - 1078-0432

VL - 14

SP - 1797

EP - 1803

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 6

ER -